• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清尿调蛋白水平与肾功能有关。

The serum uromodulin level is associated with kidney function.

出版信息

Clin Chem Lab Med. 2014 Dec;52(12):1755-61. doi: 10.1515/cclm-2014-0505.

DOI:10.1515/cclm-2014-0505
PMID:24933630
Abstract

BACKGROUND

In chronic kidney diseases of various etiologies, the urinary excretion of uromodulin is usually decreased in parallel with the glomerular filtration rate. This study aimed to investigate whether serum uromodulin is associated with kidney function.

METHODS

Within the framework of the Seniorlabor study, a subset of subjectively healthy individuals 60 years of age and older were included in the study. Serum uromodulin was measured with ELISA. The relationship between serum uromodulin and different stages of kidney function (i.e., cystatin C-based 2012-CKD-EPI eGFRCysC>90 mL/min/1.73 m2, 60-89 mL/min/1.73 m2, 45-59 mL/min/1.73 m2, and <45 mL/min/1.73 m2) was investigated. Furthermore, the relationship between serum uromodulin and other markers of kidney function (i.e., creatinine, cystatin C, and urea) was assessed.

RESULTS

In total, 289 participants (140 males/149 females; mean age 71±7 years) were included in the study. There were significant differences in serum uromodulin among the four groups according to different kidney function stages (p<0.001). Serum uromodulin displayed inverse relationships with creatinine (r=-0.39), cystatin C (r=-0.42), and urea (r=-0.30) and, correspondingly, a positive relationship with eGFRCysC (r=0.38, p<0.001 for all). These associations remained intact when fitting a regression model that incorporated age, gender, body mass index, and current smoking status as covariates.

CONCLUSIONS

Serum uromodulin behaves in a manner opposite that of the different conventional renal retention markers by displaying lower concentrations with decreasing kidney function. As uromodulin is produced by the cells of the thick ascending limb of the loop of Henle, lower uromodulin serum levels may reflect a reduction in number or function of these cells in chronic kidney disease.

摘要

背景

在各种病因引起的慢性肾脏病中,尿中尿调蛋白的排泄通常与肾小球滤过率平行下降。本研究旨在探讨血清尿调蛋白与肾功能的关系。

方法

在 Seniorlabor 研究中,纳入了年龄在 60 岁及以上的主观健康个体作为研究对象。采用 ELISA 法检测血清尿调蛋白。研究了血清尿调蛋白与不同肾功能阶段(即基于胱抑素 C 的 2012- CKD-EPI eGFRCysC>90 mL/min/1.73 m2、60-89 mL/min/1.73 m2、45-59 mL/min/1.73 m2 和<45 mL/min/1.73 m2)之间的关系。此外,还评估了血清尿调蛋白与其他肾功能标志物(即肌酐、胱抑素 C 和尿素)之间的关系。

结果

本研究共纳入 289 名参与者(140 名男性/149 名女性;平均年龄 71±7 岁)。根据不同的肾功能阶段,四组间血清尿调蛋白有显著差异(p<0.001)。血清尿调蛋白与肌酐(r=-0.39)、胱抑素 C(r=-0.42)和尿素(r=-0.30)呈负相关,与 eGFRCysC 呈正相关(r=0.38,p<0.001)。当拟合一个回归模型,纳入年龄、性别、体重指数和当前吸烟状况作为协变量时,这些相关性仍然存在。

结论

血清尿调蛋白的行为与不同的传统肾潴留标志物相反,随着肾功能的下降,其浓度降低。由于尿调蛋白是由 Henle 袢升支粗段的细胞产生的,因此血清中尿调蛋白水平降低可能反映了这些细胞在慢性肾脏病中的数量或功能减少。

相似文献

1
The serum uromodulin level is associated with kidney function.血清尿调蛋白水平与肾功能有关。
Clin Chem Lab Med. 2014 Dec;52(12):1755-61. doi: 10.1515/cclm-2014-0505.
2
Serum uromodulin concentrations correlate with glomerular filtration rate in patients with chronic kidney disease.慢性肾病患者血清尿调节蛋白浓度与肾小球滤过率相关。
Pol Arch Med Wewn. 2016 Dec 5;126(12):995-1004. doi: 10.20452/pamw.3712.
3
Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients.血浆尿调节蛋白与肾功能相关,并可识别慢性肾病患者的早期阶段。
Medicine (Baltimore). 2016 Mar;95(10):e3011. doi: 10.1097/MD.0000000000003011.
4
Serum uromodulin-a marker of kidney function and renal parenchymal integrity.血清尿调蛋白 - 肾功能和肾实质完整性的标志物。
Nephrol Dial Transplant. 2018 Feb 1;33(2):284-295. doi: 10.1093/ndt/gfw422.
5
Serum uromodulin is a novel renal function marker in the Japanese population.血清尿调蛋白是日本人血清肾功能的一项新型标志物。
Clin Exp Nephrol. 2021 Jan;25(1):28-36. doi: 10.1007/s10157-020-01964-y. Epub 2020 Sep 11.
6
Serum Uromodulin, a Potential Biomarker of Tubulointerstitial Damage, Correlates Well with Measured GFR and ERPF in Patients with Obstructive Nephropathy.血清尿调蛋白是肾小管间质损伤的潜在生物标志物,与梗阻性肾病患者的肾小球滤过率(GFR)和肾有效血浆流量(ERPF)的测量结果密切相关。
Medicina (Kaunas). 2022 Nov 26;58(12):1729. doi: 10.3390/medicina58121729.
7
Age- and sex-specific reference limits for creatinine, cystatin C and the estimated glomerular filtration rate.年龄和性别特异性肌酐、胱抑素 C 和肾小球滤过率估算值的参考范围。
Clin Chem Lab Med. 2011 Nov 14;50(5):919-26. doi: 10.1515/CCLM.2011.788.
8
[Comparison between serum cystatin C and estimation of GFR by the MDRD study equation for chronic kidney disease].[血清胱抑素C与慢性肾脏病改良饮食肾脏病研究方程估算肾小球滤过率的比较]
Nihon Jinzo Gakkai Shi. 2008;50(8):1011-6.
9
Kidney function estimating equations in patients with chronic kidney disease.慢性肾脏病患者的肾功能估算方程。
Int J Clin Pract. 2011 Apr;65(4):458-64. doi: 10.1111/j.1742-1241.2010.02597.x.
10
Performance of the creatinine-based and the cystatin C-based glomerular filtration rate (GFR) estimating equations in a heterogenous sample of patients referred for nuclear GFR testing.在接受核 GFR 检测的患者的异质样本中,基于肌酐和胱抑素 C 的肾小球滤过率(GFR)估算方程的性能。
Transl Res. 2011 Jun;157(6):357-67. doi: 10.1016/j.trsl.2011.01.002. Epub 2011 Feb 5.

引用本文的文献

1
New and Emerging Biomarkers in Chronic Kidney Disease.慢性肾脏病中的新型和新兴生物标志物
Biomedicines. 2025 Jun 10;13(6):1423. doi: 10.3390/biomedicines13061423.
2
Modifiable risk factors and plasma proteomics in relation to complications of type 2 diabetes.与2型糖尿病并发症相关的可改变风险因素和血浆蛋白质组学
Nat Commun. 2025 Mar 26;16(1):2896. doi: 10.1038/s41467-025-57830-6.
3
Serum Uromodulin as early marker for ischemic acute kidney injury and nephron loss: association with kidney tissue distribution pattern.血清尿调蛋白作为缺血性急性肾损伤和肾单位丢失的早期标志物:与肾组织分布模式的关联
J Transl Med. 2025 Mar 14;23(1):323. doi: 10.1186/s12967-025-06125-x.
4
Serum and urinary uromodulin concentration in children and young adults with chronic kidney disease.慢性肾脏病儿童及青年的血清和尿中尿调节蛋白浓度
Pediatr Nephrol. 2025 May;40(5):1751-1758. doi: 10.1007/s00467-024-06630-z. Epub 2025 Jan 11.
5
Relationship Between Serum Uromodulin as a Marker of Kidney Damage and Metabolic Status in Patients with Chronic Kidney Disease of Non-Diabetic Etiology.血清尿调蛋白作为非糖尿病病因慢性肾脏病患者肾脏损伤标志物与代谢状态的关系。
Int J Mol Sci. 2024 Oct 17;25(20):11159. doi: 10.3390/ijms252011159.
6
Advances in uromodulin biology and potential clinical applications.尿调蛋白生物学研究进展及其潜在的临床应用
Nat Rev Nephrol. 2024 Dec;20(12):806-821. doi: 10.1038/s41581-024-00881-7. Epub 2024 Aug 19.
7
Hypoaldosteronism due to a novel SEC61A1 variant successfully treated with fludrocortisone.由一种新型SEC61A1变体引起的醛固酮减少症经氟氢可的松成功治疗。
Clin Kidney J. 2024 Jul 5;17(8):sfae213. doi: 10.1093/ckj/sfae213. eCollection 2024 Aug.
8
Emerging multisystem biomarkers in hereditary transthyretin amyloidosis: a pilot study.遗传性转甲状腺素蛋白淀粉样变性症中的新兴多系统生物标志物:一项初步研究。
Sci Rep. 2024 Aug 7;14(1):18281. doi: 10.1038/s41598-024-69123-x.
9
Serum and Urinary Uromodulin in Dogs with Early Chronic Kidney Disease vs. Healthy Canine Population.患有早期慢性肾病的犬类与健康犬类群体的血清和尿液中的尿调节蛋白
Animals (Basel). 2024 Jul 18;14(14):2099. doi: 10.3390/ani14142099.
10
Unveiling the Hidden Power of Uromodulin: A Promising Potential Biomarker for Kidney Diseases.揭示尿调节蛋白的隐藏力量:一种有前景的肾脏疾病潜在生物标志物。
Diagnostics (Basel). 2023 Sep 28;13(19):3077. doi: 10.3390/diagnostics13193077.